世界の胃食道逆流症(GERD)薬市場レポート2020年

【英語タイトル】Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB5759)・商品コード:QYR21FB5759
・発行会社(調査会社):QYResearch
・発行日:2021年1月
・ページ数:133
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,120,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界の胃食道逆流症(GERD)薬市場について種類別(H2受容体拮抗薬、プロトンポンプ阻害薬(PPi)、制酸薬)、用途別(病院、診療所、医療センター、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・胃食道逆流症(GERD)薬市場の概要
・世界の主要地域別胃食道逆流症(GERD)薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の胃食道逆流症(GERD)薬市場規模2015-2026:種類別(H2受容体拮抗薬、プロトンポンプ阻害薬(PPi)、制酸薬)
・世界の胃食道逆流症(GERD)薬市場規模2015-2026:用途別(病院、診療所、医療センター、その他)
・胃食道逆流症(GERD)薬のアメリカ市場規模2015-2020
・胃食道逆流症(GERD)薬のヨーロッパ市場規模2015-2020
・胃食道逆流症(GERD)薬の中国市場規模2015-2020
・胃食道逆流症(GERD)薬の日本市場規模2015-2020
・胃食道逆流症(GERD)薬の東南アジア市場規模2015-2020
・胃食道逆流症(GERD)薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・胃食道逆流症(GERD)薬の製造コスト分析
・販売チャネル、流通業者、顧客
・胃食道逆流症(GERD)薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Gastro Esophageal Reflux Disease (GERD) Drug Market
The global Gastro Esophageal Reflux Disease (GERD) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Gastro Esophageal Reflux Disease (GERD) Drug Scope and Market Size
The global Gastro Esophageal Reflux Disease (GERD) Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastro Esophageal Reflux Disease (GERD) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Gastro Esophageal Reflux Disease (GERD) Drug market is segmented into
H2 Receptor Antagonist
Proton Pump Inhibitor (PPi)
Antacids

Segment by Application, the Gastro Esophageal Reflux Disease (GERD) Drug market is segmented into
Hospital
Clinic
Medical Center
Others

The Gastro Esophageal Reflux Disease (GERD) Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Gastro Esophageal Reflux Disease (GERD) Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Gastro Esophageal Reflux Disease (GERD) Drug Market Share Analysis
Gastro Esophageal Reflux Disease (GERD) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastro Esophageal Reflux Disease (GERD) Drug business, the date to enter into the Gastro Esophageal Reflux Disease (GERD) Drug market, Gastro Esophageal Reflux Disease (GERD) Drug product introduction, recent developments, etc.

The major vendors covered:
Pfizer
Novartis AG
GlaxoSmithKline
Merck
Medtronic

【レポートの目次】

1 Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
1.1 Gastro Esophageal Reflux Disease (GERD) Drug Product Scope
1.2 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type
1.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2020-2026)
1.2.2 H2 Receptor Antagonist
1.2.3 Proton Pump Inhibitor (PPi)
1.2.4 Antacids
1.3 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application
1.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate (2015-2026)
1.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price Trends (2015-2026)

2 Gastro Esophageal Reflux Disease (GERD) Drug Estimate and Forecast by Region
2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2015-2020)
2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2015-2026)
2.4.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2015-2026)
2.4.3 China Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2015-2026)
2.4.4 Japan Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2015-2026)
2.4.6 India Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2015-2026)
3 Global Gastro Esophageal Reflux Disease (GERD) Drug Competition Landscape by Players
3.1 Global Top Gastro Esophageal Reflux Disease (GERD) Drug Players by Sales (2015-2020)
3.2 Global Top Gastro Esophageal Reflux Disease (GERD) Drug Players by Revenue (2015-2020)
3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastro Esophageal Reflux Disease (GERD) Drug as of 2019)
3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price by Company (2015-2020)
3.5 Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Gastro Esophageal Reflux Disease (GERD) Drug Players (Opinion Leaders)
4 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2015-2020)
4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Type (2021-2026)
5 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2015-2020)
5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Application (2021-2026)

6 United States Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures
6.1 United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
6.2 United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
6.3 United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)

7 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures
7.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
7.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
7.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)

8 China Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures
8.1 China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
8.2 China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
8.3 China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)

9 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures
9.1 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (3015-3030)
9.2 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
9.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)

10 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures
10.1 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)

11 India Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures
11.1 India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
11.2 India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
11.3 India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Gastro Esophageal Reflux Disease (GERD) Drug Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Corporation Information
12.2.2 Novartis AG Business Overview
12.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
12.2.5 Novartis AG Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Business Overview
12.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Business Overview
12.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
12.4.5 Merck Recent Development
12.5 Medtronic
12.5.1 Medtronic Corporation Information
12.5.2 Medtronic Business Overview
12.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
12.5.5 Medtronic Recent Development

13 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Cost Analysis
13.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gastro Esophageal Reflux Disease (GERD) Drug
13.4 Gastro Esophageal Reflux Disease (GERD) Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors List
14.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers

15 Market Dynamics
15.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Trends
15.2 Gastro Esophageal Reflux Disease (GERD) Drug Opportunities and Drivers
15.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
15.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Gastro Esophageal Reflux Disease (GERD) Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2015-2020)
Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Region (2015-2020)
Table 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Gastro Esophageal Reflux Disease (GERD) Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Company (2015-2020)
Table 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Company (2015-2020)
Table 16. Global Gastro Esophageal Reflux Disease (GERD) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastro Esophageal Reflux Disease (GERD) Drug as of 2019)
Table 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Gastro Esophageal Reflux Disease (GERD) Drug Players
Table 22. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2015-2020)
Table 24. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2021-2026)
Table 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2021-2026)
Table 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2015-2020)
Table 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2021-2026)
Table 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2021-2026)
Table 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
Table 41. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
Table 43. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
Table 51. China Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
Table 53. China Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
Table 55. China Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
Table 69. India Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2015-2020)
Table 71. India Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
Table 73. India Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 79. Pfizer Recent Development
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 84. Novartis AG Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 94. Merck Recent Development
Table 95. Medtronic Corporation Information
Table 96. Medtronic Description and Business Overview
Table 97. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product
Table 99. Medtronic Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List
Table 103. Gastro Esophageal Reflux Disease (GERD) Drug Customers List
Table 104. Gastro Esophageal Reflux Disease (GERD) Drug Market Key Trends
Table 105. Gastro Esophageal Reflux Disease (GERD) Drug Key Opportunities and Drivers
Table 106. Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Product Picture
Figure 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Medical Center Examples
Figure 9. Others Examples
Figure 10. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Gastro Esophageal Reflux Disease (GERD) Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Gastro Esophageal Reflux Disease (GERD) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Gastro Esophageal Reflux Disease (GERD) Drug Players Market Share by Revenue in Gastro Esophageal Reflux Disease (GERD) Drug 2015 & 2019
Figure 28. Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2015-2020)
Figure 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2015-2020)
Figure 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2019
Figure 34. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2019
Figure 35. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company in 2019
Figure 36. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2019
Figure 37. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application in 2019
Figure 38. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company in 2019
Figure 39. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2019
Figure 40. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application in 2019
Figure 41. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company in 2019
Figure 42. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2019
Figure 43. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application in 2019
Figure 44. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company in 2019
Figure 45. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2019
Figure 46. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application in 2019
Figure 47. India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company in 2019
Figure 48. India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2019
Figure 49. India Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Gastro Esophageal Reflux Disease (GERD) Drug
Figure 52. Manufacturing Process Analysis of Gastro Esophageal Reflux Disease (GERD) Drug
Figure 53. Gastro Esophageal Reflux Disease (GERD) Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


【掲載企業】

Pfizer、Novartis AG、GlaxoSmithKline、Merck、Medtronic

★調査レポート[世界の胃食道逆流症(GERD)薬市場レポート2020年] (コード:QYR21FB5759)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の胃食道逆流症(GERD)薬市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆